Blood pressure target in the elderly hypertensive patient
被引:0
|
作者:
Angeli, Fabio
论文数: 0引用数: 0
h-index: 0
机构:
Univ Insubria, Dipartimento Med & Chirurg, Varese, Italy
IRCCS, Ist Maugeri, Dipartimento Med & Riabilitaz Cardiopolmonare, Tradate, VA, ItalyUniv Insubria, Dipartimento Med & Chirurg, Varese, Italy
Angeli, Fabio
[1
,2
]
Reboldi, Gianpaolo
论文数: 0引用数: 0
h-index: 0
机构:
Univ Perugia, Dipartimento Med, Perugia, ItalyUniv Insubria, Dipartimento Med & Chirurg, Varese, Italy
Reboldi, Gianpaolo
[3
]
Verdecchia, Paolo
论文数: 0引用数: 0
h-index: 0
机构:
Osped S Maria Misericordia, SC Cardiol, Perugia, Italy
Fdn Umbra Cuore & Ipertens ONLUS, Perugia, ItalyUniv Insubria, Dipartimento Med & Chirurg, Varese, Italy
Verdecchia, Paolo
[4
,5
]
机构:
[1] Univ Insubria, Dipartimento Med & Chirurg, Varese, Italy
[2] IRCCS, Ist Maugeri, Dipartimento Med & Riabilitaz Cardiopolmonare, Tradate, VA, Italy
[3] Univ Perugia, Dipartimento Med, Perugia, Italy
[4] Osped S Maria Misericordia, SC Cardiol, Perugia, Italy
Blood pressure progressively increases with age and hypertension represents one of the most prevalent and potentially modifiable risk factors in older adults. Because of the high prevalence of multiple comor-bidities and frailty, the management of hypertension in the elderly is more challenging than in younger patients. It is now soundly established from randomized clinical trials the benefit from treating hyperten-sion in older hypertensive patients, including those over the age of 80 years. Although the prognostic benefit of active treatment is indisputable, it is still debated the ideal blood pressure target in the geriatric population. A critical review of trials analyzing the benefits of different blood pressure targets in elderly pa-tients supports the notion that targeting a more intensive blood pressure goal may provide benefits which considerably outweigh the risks of unwanted effects (including hypotension, falls, acute kidney injury, and electrolyte disturbances). Furthermore, these prognostic benefits persist even in older patients who are frail. However, the optimal blood pressure control should achieve the maximum preventive benefits without causing harms or complications. In conclusion, age itself is not a barrier for treatment and it should not preclude a more intensive treatment of hypertension. Treatment should be personalized to achieve a more strict control of blood pressure (to prevent serious cardiovascular events), and to avoid over-treating frail older adults.
机构:
Midwest Cardiovasc Res Fdn, Davenport, IA 52803 USAMidwest Cardiovasc Res Fdn, Davenport, IA 52803 USA
Shammas, Nicolas W.
Sica, Domenic A.
论文数: 0引用数: 0
h-index: 0
机构:
Virginia Commonwealth Univ, Dept Med, Med Ctr, Div Nephrol, Richmond, VA 23298 USAMidwest Cardiovasc Res Fdn, Davenport, IA 52803 USA
Sica, Domenic A.
Toth, Peter P.
论文数: 0引用数: 0
h-index: 0
机构:
Midwest Cardiovasc Res Fdn, Davenport, IA 52803 USA
Sterling Rock Falls Clin, Sterling, IL USA
Univ Illinois, Coll Med, Peoria, IL 61656 USAMidwest Cardiovasc Res Fdn, Davenport, IA 52803 USA
机构:
Kobe Pharmaceutical University,Laboratory of Epidemiology and PreventionKobe Pharmaceutical University,Laboratory of Epidemiology and Prevention
Sachiko Tanaka-Mizuno
Fumiko Nakatsu
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharma K.K.,Medical AffairsKobe Pharmaceutical University,Laboratory of Epidemiology and Prevention
Fumiko Nakatsu
Shunsuke Eguchi
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharma K.K.,Medical AffairsKobe Pharmaceutical University,Laboratory of Epidemiology and Prevention
Shunsuke Eguchi
Kazuma Iekushi
论文数: 0引用数: 0
h-index: 0
机构:
Novartis Pharma K.K.,Medical AffairsKobe Pharmaceutical University,Laboratory of Epidemiology and Prevention
Kazuma Iekushi
Hironori Nakagami
论文数: 0引用数: 0
h-index: 0
机构:
Osaka University Graduate School of Medicine,Department of Health Development and MedicineKobe Pharmaceutical University,Laboratory of Epidemiology and Prevention